The authors demonstrated reduced VEGF expression and impaired cell proliferation and migration in a renal cell carcinoma cell line (Caki-1), and slower tumor growth in mice bearing RCC xenografts, following treatment with the ASO directed against VEGF. The gene discussed is VEGFA; the disease is hereditary clear cell renal cell carcinoma.